Saudi’s Abdul Latif Jameel Health launches “pioneering” heart surgery procedure in the GCC

A recently established healthcare solutions provider has partnered with Saudi Arabia Ministry of Health Bringing a “groundbreaking” heart surgery practice to the Kingdom.

Abdul Latif Jameel Health – which was founded in 2020 with the Mission to combat “inequality in access to modern medical care” – brought it to life AVNeo (Aortic valve neo-cuspitization), used in the surgical reconstruction of the aortic heart valve. It is described as a cheaper yet safe alternative This creates a movement that approximates that of a natural valve compared to other aortic valve replacement procedures.

The partnership marks the AVNeo’s debut on the Gulf Cooperation Council (GCC). This makes Saudi Arabia the first country in the region to offer this advanced solution.

“We want to facilitate and explore the possibility of applying such innovative medical technology solutions in the UK’s hospitals to provide high quality integrated health care services,” said Najlaa Kateb, Director General of the Innovation Center in the Ministry of Health. “The ministry is continuing its efforts through the Future Foresight program at the Innovation Center, which aims to take the latest medical technology solutions and make them available to patients.”

THE GREATER CONTEXT

First Introduced in Japan in 2007Since then, the AVNeo has been implemented in over 20 countries, including the USA, Germany, Russia, Italy and the UK. It takes advantage of a patient’s pericardial tissue, reducing the cost of surgery and reducing the chance of an allergic reaction.

Those undergoing the procedure will likely not need to take any medication for six months after the operation.

According to Abdul Latif Jameel Health, “the 10 year survival rate was 85.9% for those who received AVNeo compared to less than 80% for alternative procedures.”

The technique is reportedly suitable for all ages, including children.

WHY IT IS IMPORTANT

According to the country’s Ministry of Health, Cardiovascular disease accounts for 37% of all deaths in Saudi ArabiaWhile 15% of the UK’s population suffer from high blood pressure – a significant risk factor.

Both the ministry and Abdul Latif Jameel Health are in the process of obtaining formal approval for the new medical technology from the Saudi Food and Drug Administration. This includes setting up a program to train medical professionals to perform AVNeo operations under the supervision of Adel Tash, Adult Consultant Cardiac Surgeon at the Department of Health. It is hoped that these trained surgeons will be able to perform the operation both inside and outside the country.

ON THE RECORDING

“We are proud to be working with the Ministry of Health, a pioneer in the health sector who is implementing innovative projects to improve patient services,” said Faisal Alsamannoudi, Vice Chairman and CEO of Abdul Latif Jameel Enterprises. “Over the past 75 years, Abdul Latif Jameel has transformed from a local company into a globally diversified company. The establishment of Abdul Latif Jameel Health is an important milestone on this path. Working together on projects like AVNeo will undoubtedly pave the way for more groundbreaking innovations in our future work.

“This collaboration is also an incentive for Abdul Latif Jameel Health, as part of his contribution to the National Transformation Program and the Quality of Life Program, to promote continuous research and development for the benefit of this nation and its people. Line with the Saudi Vision 2030.”

Comments are closed.